OCCURRENCE RATE OF HIGH RISK HISTOLOGICAL FEATURES IN PRIMARY ENUCLEATION SPECIMENS OF PEDIATRIC RETINOBLASTOMA PATIENTS: A LOCAL EXPERIENCE
DOI:
https://doi.org/10.55519/JAMC-04-13984Keywords:
Children; Eye; High risk Histology (HRH); RetinoblastomaAbstract
Background: Retinoblastoma is the most common primary intraocular malignancy of childhood. The majority of cases are seen in children aged <5 years. The incidence of retinoblastoma is approximately 1 in 15,000 to 20,000 live births worldwide. Unfortunately, more than 3000 children die of retinoblastoma every year, with mortality rates being significantly higher in Asia and Africa.
Objective was to determine frequency of high risk histological features in primary enucleated eye specimens having retinoblastoma for deciding therapeutic strategies. This cross-sectional study, conducted at the Histopathology department of Foundation University Medical College in Rawalpindi, aimed to determine the frequency of high-risk histological features in primary enucleated eye specimens with retinoblastoma to inform therapeutic strategies. Over a year, from September 25, 2019, to September 24, 2020. Methods: After approval from ethical review board, all patients fulfilling the inclusion criteria were enrolled in the study. All the demographic details of the patients including age, gender, duration since the diagnosis and family history of retinoblastoma were obtained. The specimens of retinoblastoma received form eye department were marked. Freshly cut 3-5 microns thick sections stained with Hematoxylin and Eosin (H & E) were examined microscopically by a team of two histopathologists. The presence or absence of high risk histological features was reported /recorded in the designed proforma. Results: A total of 150 patients were included in the study. The mean age of the patients was found to be 2.51 ± 1.30 years. The gender distribution showed that most of the patients were males. The mean duration since diagnosis was 4.70 ± 2.81 months. Positive choroid invasion was found in 25 patients (16.7%) and optic nerve invasion was found in 77 patients (51.3%). Conclusion: The study showed that optic nerve invasion was found in significant number of patients and was more prevalent than choroid invasion in patients with retinoblastoma. This will help our clinicians to better guide our patients regarding the prognosis of the disease and deciding the treatment options for the patients.
References
1. Fabian ID, Reddy A, Sagoo MS. Classification and staging of retinoblastoma. Community eye health. 2018 May 19;31(101):11-3.
2. Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Boubacar SA, Ademola-Popoola DS,et al. Global retinoblastoma presentation and analysis by national income level. JAMA oncology. 2020 May 1;6(5):685-95.
3. Koochakzadeh L, Yekta A, Hashemi H, Pakzad R, Heydarian S, Khabazkhoob M. Epidemiological aspect of retinoblastoma in the world: a review of recent advance studies. Int J Ophthalmol. 2023 Jun 18;16(6):962-968. doi: 10.18240/ijo.2023.06.20.
4. Sherief ST, Wu F, O’Banion J, Teshome T, Dimaras H. Referral patterns for retinoblastoma patients in Ethiopia. BMC Health Services Research. 2023 Feb 20;23(1):172.
5. Kugalingam N, de Silva D, Abeysekera H, Nanayakkara S, Tirimanne S, Chandrasekharan V, et al. Retinoblastoma patients treated in Sri Lanka from 2014 to 2020: epidemiology, clinical status and correlates of lag time in seeking tertiary care services. BMC ophthalmology. 2024 Jul 17;24(1):292.
6. Shaheen N, Inayat N, Bashir S, Sheikh UN, Bakar MA, Rehman P. Survival outcomes of unilateral retinoblastoma based on pathological risk stratification-experience at a tertiary care centre in Pakistan. e cancer medical science. 2022;16.
7. Mohammad M, Shehada R, Al-Nawaiseh I, Mehyar M, AlHussaini M, Jaradat I,et al. A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma. European Journal of Ophthalmology. 2023 Sep;33(5):2014-23.
8. Chévez-Barrios P, Eagle Jr RC, Krailo M, Piao J, Albert DM, Gao Y, et al. Study of unilateral retinoblastoma with and without histopathologic high-risk features and the role of adjuvant chemotherapy: a Children’s Oncology Group Study. Journal of Clinical Oncology. 2019 Nov 1;37(31):2883-91.
9. Fabian ID, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I, et al. The management of retinoblastoma. Oncogene. 2018 Mar 22;37(12):1551-60
10. Vuhahula EA, Jumanne S, Yahaya J. Expression of Ki67 as detected by MIB-1 and its association with histopathological high-risk factors among patients with retinoblastoma tumour: a cross-sectional study. BMJ Open Ophthalmology. 2022 Sep 1;7(1):e000984.
11. Kaewkhaw R, Rojanaporn D. Retinoblastoma: etiology, modeling, and treatment. Cancers. 2020 Aug 16;12(8):2304.
12. Xie Y, Xu XL, Wei WB. The RB1 mutation spectrum and genetic management consultation in pediatric patients with retinoblastoma in Beijing, China. Risk management and healthcare policy. 2021 Aug 21:3453-63.
13. Kaliki S, Gupta S, Ramappa G, Mohamed A, Mishra DK. High-risk retinoblastoma based on age at primary enucleation: a study of 616 eyes. Eye. 2020 Aug;34(8):1441-8.
14. Miranda GA, Simanjuntak GW. Clinical findings and demography of retinoblastoma in a tertiary hospital in a remote area in a developing country. Asian Pacific Journal of Cancer Care. 2018 Jun 19;3(2):37-
15. Gupta SK, Meshram M, Kumar A, Verma N, Agrawal S, Kumar A. Survival and outcome of retinoblastoma treated by neo-adjuvant chemotherapy in India. Cancer Rep. 2019;2(3):e1137.
16. Zia N, Ahmer Hamid A, Iftikhar S, Qadri MH, Jangda A, Khan MR. Retinoblastoma Presentation and Survival: A four-year analysis from a tertiary care hospital. Pakistan Journal of Medical Sciences. 2019 Nov 28;36(1):61-6.
17. Jain M, Rojanaporn D, Chawla B, Sundar G, Gopal L, Khetan V. Retinoblastoma in Asia. Eye. 2019 Jan;33(1):87-96.
18. Amin S, AlJboor M, Toro MD, Rejdak R, Nowomiejska K, Nazzal R, et al. Management and outcomes of unilateral group D tumors in retinoblastoma. Clinical Ophthalmology. 2021 Jan 7:65-72.
19. Kaliki S, Shields CL, Eagle Jr RC, Iram S, Shields JA. High-risk intraocular retinoblastoma: Comparison between Asian Indians and Americans from two major referral centers. Retina. 2018 Oct 1;38(10):2023-9.
20. Nur Melani Sari; Regina Hadiputri; Maya Sari Kuntorini; Hasrayati Agustina;Friska Mardianty. High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia Ocul Oncol Pathol (2021) 7 (5): 353–360.
21. Yaqoob N, Mansoor S, Aftab K, Kaleem B, Hamid A, Jamal S. High risk histopathological factors in retinoblastoma in upfront enucleated eyes: An experience from a tertiary care centre of Pakistan. Pak J Med Sci. 2022 Jan;38(2):369-374.
22. Alkatan HM, AlQahtani FS, Maktabi AM. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC). International Ophthalmology. 2020 Jul;40:1739-47.
23. Yuliawati P, Ekawati NP. Pathological risk factor profile for enucleated retinoblastoma at Sanglah General Hospital. Biomedical & Pharmacology Journal. 2018;11(4):2031.
24. Yahaya JJ, Rugwizangoga B, Mremi A, Munema A. Clinicopathological Findings of Retinoblastoma: A 10‐Year Experience from a Tertiary Hospital in Kampala, Uganda. Journal of Ophthalmology. 2019;2019(1):5829284.
25. Yaqoob N, Mansoor S, Zia N, Aftab K, Kaleem B, Jamal S. Chemotherapy induced histopathological changes in retinoblastoma, assessment of high risk predictive factors & its correlation with comorbid conditions. Pakistan Journal of Medical Sciences. 2022 Jan;38(2):362.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Natasha Sherazi, Iram Kehkashan Khurshid, Mahwish Niaz, Hira Arif, Zunaira Qayyum, Maryam Waqar
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
